South Korean medical AI leader VUNO has today announced a landmark strategic memorandum of understanding (MOU) with European partners Contextflow and Mesalvo, paving the way for large-scale rollout of its AI-powered patient monitoring solution DeepCARS across the European hospital landscape. The agreement was unveiled at ESICM 2025, with VUNO executives presenting DeepCARS capabilities—most notably, its ability to predict in-hospital cardiac arrest risk up to 24 hours in advance using comprehensive patient vital sign analysis. This partnership is expected to extend VUNO's AI monitoring reach to more than 900 hospitals throughout Europe, marking one of the continent's largest cross-border implementations of advanced, AI-based clinical decision support systems.

DeepCARS represents a next-generation digital transformation initiative for European critical care and patient monitoring segments. The platform harnesses advanced algorithms trained on a diverse dataset of bio signals, including ECG, blood pressure, heart rate, respiratory rate, and temperature, alongside medical images such as X-rays and CT scans, to detect and assess emergent cardiac risks in general ward environments. According to VUNO, real-world deployments in over 20 tertiary general hospitals and 50,000 beds in South Korea have demonstrated improved early risk stratification, accelerated clinical intervention, and overall enhancements in cardiac arrest prevention. These results are underpinned by proven accuracy, regulatory advances—including 'Breakthrough Device Designation' from the U.S. FDA—and growing recognition among European hospital intensivists and critical care professionals.

The partnership with Contextflow and Mesalvo is specifically tailored to the European hospital context, leveraging local expertise, regulatory insights, and existing network infrastructure to drive adoption and compliance. In addition to technological rollout, the firms have structured ongoing educational outreach and hands-on demonstration to further engagement among clinical leadership, nurse managers, biomedical engineers, and hospital procurement teams. VUNO's involvement at ESICM 2025—including dedicated showcase booths and live clinical case workshops—has drawn robust interest from intensive care and emergency medicine communities, indicating pent-up demand for advanced digital solutions that can translate complex multi-modal patient data into actionable risk alerts for clinicians.

AI-powered patient monitoring and risk prediction is emerging as a foundational shift in European hospital operations, directly impacting procurement strategies, critical care resourcing, infrastructure planning, and clinical workflow optimization. The DeepCARS solution, in particular, aligns with the priorities of facilities seeking to reduce preventable adverse events, optimize early warning systems, and support multidisciplinary care teams in time-sensitive environments. For hospital administrators and technology procurement professionals, the integration of DeepCARS underscores a larger movement toward interoperable, scalable digital platforms that can seamlessly interface with electronic health records (EHR), integrate with legacy sensor infrastructure, and support compliance with evolving European digital health regulations.

Clinical leadership teams are expected to benefit from DeepCARS' modular design, real-time data interpretation features, and its demonstrated capacity to reduce clinical escalation timeframes. As discussions advance, the strategic alliance will also explore joint research initiatives, pan-European clinical validation studies, and regional training programs to standardize the implementation and assessment protocol, further embedding AI as a core innovation driver in Europe's hospital patient monitoring and emergency care infrastructure.